Skip to main content
. 2022 Jun 16;139(24):3505–3518. doi: 10.1182/blood.2021014723

Figure 6.

Figure 6.

Outcome analyses of CDX2/UBTF ALL patients. Cumulative incidence of relapse (A) and OS (B) Kaplan-Meier curves for B-ALL patients enrolled in GRAALL-2005/2014 trials according to CDX2/UBTF ALL status. (C) Univariate and multivariate outcome analyses for CDX2/UBTF ALL patients. *Continuous variables. WBC, white blood cell count.